Stockreport

IN8bio to Present at Biotech Showcase 2025 in San Francisco

IN8bio, Inc.  (INAB) 
PDF NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, [Read more]